StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)

Close on Nov 13, 2026Market cap $342.73MP/E –Yield –

Treace Medical Concepts enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Treace Medical Concepts's enterprise value was $338.73M on Nov 11, 2026, against $185.30M a year earlier. Over the last 5 years it ranged from $93.74M to $1.51B, with a median of $530.51M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$338.73M+122.9%
2025Dec 31, 2025$151.97M-65.0%
2024Dec 31, 2024$433.76M-39.4%
2023Dec 29, 2023$716.26M-42.2%
2022Dec 30, 2022$1.24B+66.6%
2021Dec 31, 2021$744.19M–

More Treace Medical Concepts figures

See a number that looks wrong?